Home
With ge nomic and protein biomarker analysis now a cornerstone of personalized cancer care, translational advancements and novel methodologies play a powerful role in improving patient outcomes. The Third Transatlantic Exchange in Oncology, led by thought leaders from Dana-Farber Cancer Institute and Gustave Roussy with the support of L’ Institut Servier, examines the utility of liquid biopsy as a window into oncogenic activity across the disease pathway for a multitude of cancers. Join us in Boston or